BioSpace News Archive

New fund will invest growth capital in Atlas-backed biotech companies

Pursuing medical cannabinoids for a variety of pain indications

ImaginAb Inc. announced today the appointment of Friedhelm Blobel, Ph.D., former President and Chief Executive Officer of SciClone Pharmaceuticals, Inc. as an independent non-executive Director to its Board of Directors.

Bruker Corporation announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco.

Prana Biotechnology Ltd has today announced that it has entered into a securities purchase agreement for a lead investment by Boston based Life Biosciences LLC (“Life Biosciences”) to raise up to approximately A$44.5 million

NanoViricides, Inc. today announced it will be featured as a presenting company at the Biotech ShowcaseTM Investor Conference.

Ionis Pharmaceuticals, Inc. today announced that Management will present a Company overview at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 4:00 p.m. PT in San Francisco, CA.

Dr. Shigeru Saito Treats First Patient at Shonan Kamakura General Hospital

Results are expected in the second half of 2019

Acceleron Pharma Inc. today announced that Habib Dable, President and Chief Executive Officer, will present an overview of the company along with its upcoming corporate priorities at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 2:00 p.m. PST / 5:00 p.m. EST in San Francisco, California.